Boehringer Ingelheim's Pradaxa approved in Canada
German pharmaceutical company Boehringer Ingelheim said Wednesday its oral blood-thinning drug Pradaxa for the prevention of stroke and embolism in patients with irregular heart beat has been approved in Canada.
A new type 2 diabetes pill known as Tradjenta from Boehringer, a German company, and Indianapolis-based Eli Lilly & Co. has been approved by the Food and Drug Administration.